Biand tricyclic substituted phenyl methanones as glycine transporter I (GlyT-1) inhibitors for the treatment of Alzheimer's disease
Details for Australian Patent Application No. 2005315914 (hide)
International Classifications
Event Publications
28 June 2007 PCT application entered the National Phase
PCT publication WO2006/063709 Priority application(s): WO2006/063709
2 August 2007 Change of Name(s) of Applicant(s), Section 104
F.Hoffmann-La Roche AG The name of the applicant has been changed to F. Hoffmann-La Roche AG
3 March 2011 Application Accepted
Published as AU-B-2005315914
30 June 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005315919-Pharmaceutical compositions for the treatment of cellulite
2005315913-Tetracyclic imidazo-benzodiazepines as GABA receptors modulators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser